Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1574-8936
  • E-ISSN: 2212-392X

Abstract

Background

Echinococcosis, a parasitic disease caused by the larvae of the Echinococcus parasite, poses a serious threat to human health. Medication is an indispensable means of treatment for Echinococcosis; however, due to the less satisfactory efficacy of single drugs, identifying effective drug combinations for the treatment of Echinococcosis is essential. Yet, current predictive models for drug synergy in Echinococcosis face accuracy challenges due to data scarcity, method limitations, and insufficient feature representation.

Objective

This work aims to design an end-to-end method to predict drug synergistic combinations, which enables efficient and accurate identification of drug combinations against Echinococcosis.

Methods

In this work, an end-to-end method, named DSPE, is proposed for predicting anti-Echinococcosis drug synergistic combinations. In DSPE, a dataset of Echinococcosis drug synergistic combinations is constructed by retrieving and extracting information from related scientific articles. Further, DSPE employs a residual graph attention network to deeply analyze drug characteristics and their interactions, thereby enhancing the performance of deep learning models. It also explores the protein-protein interaction network related to Echinococcosis, using node2vec combined with an attention mechanism to efficiently encode disease features. Finally, it predicts the synergy of drug combinations based on the Bliss score by integrating drug combinations and disease features.

Results

Experimental evidence shows that DSPE outperforms five state-of-the-art algorithms in predicting drug combination effects by leveraging disease-target information and single-agents for the treatment.

Conclusion

DSPE improves prediction accuracy and addresses the issue of data scarcity for new diseases, offering new insights and methods for the development of treatment plans for parasitic diseases in the future.

Loading

Article metrics loading...

/content/journals/cbio/10.2174/0115748936325300241009051347
2025-01-07
2026-02-17
Loading full text...

Full text loading...

References

  1. LupiaT. CorcioneS. GuerreraF. Pulmonary echinococcosis or lung hydatidosis: A narrative review.Surg. Infect. (Larchmt.)202122548549510.1089/sur.2020.197 33297827
    [Google Scholar]
  2. RosaF.G.D. Alveolar Echinococcosis in immunocompromised hosts. Clinical microbiology and infection.European Soc Clin Microbiol Infect Dis2023202329
    [Google Scholar]
  3. WeberT.F. JunghanssT. StojkovićM. Pulmonary cystic echinococcosis.Curr. Opin. Infect. Dis.202336531832510.1097/QCO.0000000000000962 37578473
    [Google Scholar]
  4. HabibiB. GholamiS. BagheriA. FakharM. MoradiA. Khazeei TabariM.A. Cystic echinococcosis microRNAs as potential noninvasive biomarkers: Current insights and upcoming perspective.Expert Rev. Mol. Diagn.2023231088589410.1080/14737159.2023.2246367 37553726
    [Google Scholar]
  5. TorkamanniaA. OmidiY. FerdousiR. A review of machine learning approaches for drug synergy prediction in cancer.Brief. Bioinform.2022233bbac07510.1093/bib/bbac075 35323854
    [Google Scholar]
  6. ChaiJ.Y. JungB.K. HongS.J. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: An update.Korean J. Parasitol.202159318922510.3347/kjp.2021.59.3.189 34218593
    [Google Scholar]
  7. WangC.C. ZhaoY. ChenX. Drug-pathway association prediction: From experimental results to computational models.Brief. Bioinform.2021223bbaa06110.1093/bib/bbaa061 32393976
    [Google Scholar]
  8. ZhengW. SunW. SimeonovA. Drug repurposing screens and synergistic drug-combinations for infectious diseases.Br. J. Pharmacol.2018175218119110.1111/bph.13895 28685814
    [Google Scholar]
  9. SałatR. SałatK. The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin-induced diabetic neuropathy.Comput. Methods Programs Biomed.2013111233033710.1016/j.cmpb.2013.04.018 23693136
    [Google Scholar]
  10. KimY. ZhengS. TangJ. Jim ZhengW. LiZ. JiangX. Anticancer drug synergy prediction in understudied tissues using transfer learning.J. Am. Med. Inform. Assoc.2021281425110.1093/jamia/ocaa212 33040150
    [Google Scholar]
  11. QiY. Random Forest for Bioinformatics.2012Available From: https://www.cs.cmu.edu/~qyj/papersA08/11-rfbook.pdf
    [Google Scholar]
  12. LiuH. ZhangW. NieL. DingX. LuoJ. ZouL. Predicting effective drug combinations using gradient tree boosting based on features extracted from drug-protein heterogeneous network.BMC Bioinformatics201920164510.1186/s12859‑019‑3288‑1 31818267
    [Google Scholar]
  13. ShiJ.Y. LiJ.X. GaoK. LeiP. YiuS.M. Predicting combinative drug pairs towards realistic screening via integrating heterogeneous features.BMC Bioinformatics201718S12Suppl. 1240910.1186/s12859‑017‑1818‑2 29072137
    [Google Scholar]
  14. LinW. WuL. ZhangY. An enhanced cascade-based deep forest model for drug combination prediction.Brief. Bioinform.2022232bbab56210.1093/bib/bbab562 35062018
    [Google Scholar]
  15. LinX. DaiL. ZhouY. Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction.Brief. Bioinform.2023244bbad23510.1093/bib/bbad235 37401373
    [Google Scholar]
  16. PreuerK. LewisR.P.I. HochreiterS. BenderA. BulusuK.C. KlambauerG. DeepSynergy: Predicting anti-cancer drug synergy with Deep Learning.Bioinformatics20183491538154610.1093/bioinformatics/btx806 29253077
    [Google Scholar]
  17. WangJ. LiuX. ShenS. DengL. LiuH. DeepDDS: Deep graph neural network with attention mechanism to predict synergistic drug combinations.Brief. Bioinform.2022231bbab39010.1093/bib/bbab390 34571537
    [Google Scholar]
  18. YangJ. XuZ. WuW.K.K. ChuQ. ZhangQ. GraphSynergy: A network-inspired deep learning model for anticancer drug combination prediction.J. Am. Med. Inform. Assoc.202128112336234510.1093/jamia/ocab162 34472609
    [Google Scholar]
  19. LiH. ZouL. KowahJ.A.H. Predicting drug synergy and discovering new drug combinations based on a graph autoencoder and convolutional neural network.Interdiscip. Sci.202315231633010.1007/s12539‑023‑00558‑y 36943614
    [Google Scholar]
  20. WangT. WangR. WeiL. AttenSyn: An attention-based deep graph neural network for anticancer synergistic drug combination prediction.J. Chem. Inf. Model.2023 37565997
    [Google Scholar]
  21. XuM. ZhaoX. WangJ. DFFNDDS: Prediction of synergistic drug combinations with dual feature fusion networks.J. Cheminform.20231513310.1186/s13321‑023‑00690‑3 36927504
    [Google Scholar]
  22. VeličkovićP. CucurullG. CasanovaA. Graph attention networks.arXiv:1710109032018
    [Google Scholar]
  23. GroverA. LeskovecJ. node2vec: Scalable feature learning for networks.arXiv:1607006532016
    [Google Scholar]
  24. PandeyM. RadaevaM. MslatiH. Ligand binding prediction using protein structure graphs and residual graph attention networks.Molecules20222716511410.3390/molecules27165114 36014351
    [Google Scholar]
  25. RouillardA.D. GundersenG.W. FernandezN.F. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins.Database (Oxford)20162016baw10010.1093/database/baw100 27374120
    [Google Scholar]
/content/journals/cbio/10.2174/0115748936325300241009051347
Loading
/content/journals/cbio/10.2174/0115748936325300241009051347
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test